164 related articles for article (PubMed ID: 22926906)
21. Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles.
Donato LJ; Karras RM; Katzmann JA; Murray DL; Snyder MR
Respir Res; 2015 Aug; 16(1):96. PubMed ID: 26243289
[TBL] [Abstract][Full Text] [Related]
22. Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of alpha1-antitrypsin deficiency in Asia.
de Serres FJ; Blanco I; Fernández-Bustillo E
Eur Respir J; 2006 Dec; 28(6):1091-9. PubMed ID: 17005586
[TBL] [Abstract][Full Text] [Related]
23. Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparison.
Mattman A; Gilfix BM; Chen SX; DeMarco ML; Kyle BD; Parker ML; Agbor TA; Jung B; Selvarajah S; Barakauskas VE; Vaags AK; Estey MP; Nelson TN; Speevak MD
Clin Biochem; 2020 Jul; 81():27-33. PubMed ID: 32387440
[TBL] [Abstract][Full Text] [Related]
24. Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states.
Joly P; Guillaud O; Hervieu V; Francina A; Mornex JF; Chapuis-Cellier C
Orphanet J Rare Dis; 2015 Oct; 10():130. PubMed ID: 26446624
[TBL] [Abstract][Full Text] [Related]
25. Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries.
Blanco I; de Serres FJ; Fernandez-Bustillo E; Lara B; Miravitlles M
Eur Respir J; 2006 Jan; 27(1):77-84. PubMed ID: 16387939
[TBL] [Abstract][Full Text] [Related]
26. [Development of a laboratory test on dried blood spots for facilitating early diagnosis of alpha-1-antitrypsin deficiency].
Balduyck M; Chapuis Cellier C; Roche D; Odou MF; Joly P; Madelain V; Vergne A; Nouadje G; Lafitte JJ; Porchet N; Beaune P; Zerimech F
Ann Biol Clin (Paris); 2014; 72(6):689-704. PubMed ID: 25486665
[TBL] [Abstract][Full Text] [Related]
27. A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height.
North TL; Ben-Shlomo Y; Cooper C; Deary IJ; Gallacher J; Kivimaki M; Kumari M; Martin RM; Pattie A; Sayer AA; Starr JM; Wong A; Kuh D; Rodriguez S; Day IN
J Med Genet; 2016 Apr; 53(4):280-8. PubMed ID: 26831755
[TBL] [Abstract][Full Text] [Related]
28. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
[TBL] [Abstract][Full Text] [Related]
29. Emerging drugs for alpha-1-antitrypsin deficiency.
Stockley RA
Expert Opin Emerg Drugs; 2010 Dec; 15(4):685-94. PubMed ID: 20716026
[TBL] [Abstract][Full Text] [Related]
30. PCR-based screening for the most prevalent alpha 1 antitrypsin deficiency mutations (PI S, Z, and Mmalton) in COPD patients from Eastern Tunisia.
Denden S; Lakhdar R; Keskes NB; Hamdaoui MH; Chibani JB; Khelil AH
Biochem Genet; 2013 Oct; 51(9-10):677-85. PubMed ID: 23666394
[TBL] [Abstract][Full Text] [Related]
31. A rare variant of α 1 antitrypsin mutations detected in Vietnamese children with liver disease.
Hoàng TH; Phạm TN; Nguyễn GK; Lê QH
Ann Clin Biochem; 2013 Jul; 50(Pt 4):339-44. PubMed ID: 23766346
[TBL] [Abstract][Full Text] [Related]
32. Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease.
Blanco I; Diego I; Castañón C; Bueno P; Miravitlles M
Arch Bronconeumol; 2023 Jul; 59(7):427-434. PubMed ID: 37045725
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review.
de Serres FJ; Blanco I
Ther Adv Respir Dis; 2012 Oct; 6(5):277-95. PubMed ID: 22933512
[TBL] [Abstract][Full Text] [Related]
34. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
35. The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil.
Felisbino MB; Fernandes FLA; Nucci MCNM; Pinto RMC; Pizzichini E; Cukier A
J Bras Pneumol; 2018; 44(5):383-389. PubMed ID: 30517339
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of α-1-antitrypsin gene mutations in Saudi Arabia.
Aljarallah B; Ali A; Dowaidar M; Settin A
Saudi J Gastroenterol; 2011; 17(4):256-60. PubMed ID: 21727732
[TBL] [Abstract][Full Text] [Related]
37. Analysis of two common alpha 1-antitrypsin deficiency alleles (PI*Z and PI*S) in subjects with periodontitis.
Scott DA; von Ahsen N; Palmer RM; Wilson RF
J Clin Periodontol; 2002 Dec; 29(12):1118-21. PubMed ID: 12492914
[TBL] [Abstract][Full Text] [Related]
38. Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population.
Simsek H; Pinar A; Altinbas A; Alp A; Balaban YH; Buyukasik Y; Ozcebe O; Hascelik G; Gedikoglu G; Tatar G
J Clin Lab Anal; 2011; 25(4):296-9. PubMed ID: 21786332
[TBL] [Abstract][Full Text] [Related]
39. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
[TBL] [Abstract][Full Text] [Related]
40. Lessons from the Past: Some Histories of Alpha-1 Antitrypsin Deficiency Before Its Discovery.
Perciaccante A; Charlier P; Negri C; Coralli A; Appenzeller O; Bianucci R
COPD; 2018 Feb; 15(1):1-3. PubMed ID: 29469675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
